Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5867 posts found.

EU gives the nod to Teva/Lonza biosimilar venture

May 18, 2009 Manufacturing and Production, Sales and Marketing Lonza, Teva

The European Commission has given a green light to the formation of a joint venture company between Teva and Lonza …
News

Sanofi-Aventis starts work on dengue fever plant

May 15, 2009 Manufacturing and Production Sanofi-Aventis

Sanofi-Aventis' vaccine subsidiary Sanofi Pasteur has broken ground on a 350 million euro facility devoted to the producing a vaccine …
News

API market growth driven by biologics

May 13, 2009 Manufacturing and Production biologics

The global market for active pharmaceutical ingredients is being transformed as big pharma companies devote more and more resources to …
News

Pharma manufacturing: news in brief

May 12, 2009 Manufacturing and Production Genzyme

Pharmafocus presents a round-up of developments in the pharmaceutical manufacturing sector, including new capital investments at Roche, Genzyme and Aeras, …
News

RMG wins preferred supplier status

May 12, 2009 Manufacturing and Production Roche

News

Sanofi hikes flu vaccine capacity with new US plant

May 11, 2009 Manufacturing and Production Sanofi-Aventis, h1n1

Sanofi-Aventis has been given a green light for a new $150 million flu vaccine manufacturing plant in the US that …
News

Allergan closes doors on Irish plant

May 8, 2009 Manufacturing and Production Allergan

US drugmaker Allergan has brought the curtain down on its manufacturing facility in Arklow, Ireland, months ahead of schedule. The …
News

Sanofi-Aventis makes 200m euro push into antibodies

May 7, 2009 Manufacturing and Production Sanofi-Aventis, biologicals

Sanofi-Aventis will spend 200 million euros to convert one of its facilities near Paris into a biotechnology facility which is …
News

Pharma manufacturing: news in brief

May 6, 2009 Manufacturing and Production Pfizer

Pharmafocus presents a round-up of developments in the pharmaceutical manufacturing sector, including Pfizer's increased adoption of contract manufacturing and facility …
News

EDQM takes issue with more Chinese APIs

May 5, 2009 Manufacturing and Production Asia, China

The European Directorate on the Quality of Medicines has suspended the certificates of suitability (CEPs) of four active pharmaceutical ingredients …
News

Patheon takeover stymied by regulators

April 28, 2009 Manufacturing and Production Patheon

A hostile takeover bid for Canadian contract manufacturer Patheon by private equity firm JLL Partners has been blocked by the …
News

Mixed news for Biogen Idec on Tysabri

April 27, 2009 Manufacturing and Production Biogen

Biogen Idec has won approval for a new high-titre manufacturing process for its multiple sclerosis product Tysabri (natalizumab) which should …
News

Deal brings single ASEAN pharma market closer

April 22, 2009 Manufacturing and Production Asia

An accord signed by economic ministers of the Association of Southeast Asian Nations, aimed at bringing manufacturing standards into line, …
News

Sanofi manufacturing plant closed by Italian earthquake

April 17, 2009 Manufacturing and Production Europe, Italy, Sanofi-Aventis

A manufacturing facility operated by Sanofi-Aventis in Abruzzo, Italy, remains closed following the earthquake that claimed more than 280 lives …
News

Amgen cuts back at US pilot plant

April 16, 2009 Manufacturing and Production Amgen

The worlds largest biotech company, Amgen, is cutting 100 staff at its production facility in Bothell, Washington, as part of …
News
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026